Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.45 |
| ▸ | CES1 | P23141 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4673078 | 0.85 | CES2 (0.42) | CES2CES1CHRM1CHRM2CHRM3 | |
| SCHEMBL4672734 | 0.82 | CPN1 (0.39) | CHRM1CHRM2CHRM3SLC6A4SLC6A2 | |
| SCHEMBL4670554 | 0.75 | CES2 (0.45) | CES2CES1L3MBTL1SLC6A4SLC6A2 | |
| SCHEMBL9411466 | 0.74 | ACKR3 (0.47) | CES2CES1L3MBTL1CHRM1CHRM2 | |
| Hydrochloric Acid SCHEMBL9411652 | 0.73 | ACKR3 (0.46) | CES2CES1L3MBTL1CHRM1CHRM2 | |
| SCHEMBL4672830 | 0.72 | CES2 (0.52) | CES2CES1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL1836446 | 0.71 | CES2 (0.50) | CES2CES1L3MBTL1 | |
| SCHEMBL4674068 | 0.70 | SLC6A2 (0.40) | CHRM1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL3583032 | 0.70 | SMN1; SMN2 (0.40) | CES2CES1L3MBTL1SLC6A4SLC6A2 | |
| SCHEMBL4670637 | 0.69 | CES2 (0.39) | CES2CES1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1899324-A2 | BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS | Theravance, Inc. (US) | 2008-03-19 | — | — | EP | disclosed |
| WO-2006127815-A2 | BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS | THERAVANCE, INC. (US) | 2006-11-30 | — | — | WO | disclosed |